Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parinaz Aliahmad

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Communications Medicine|September 24, 2025
Durability of next-generation self-replicating RNA vaccine RBI-4000: a phase 1, randomized open label clinical trialChristian J Maine, Gaelle Picarda, Shigeki J Miyake-Stoner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 12, 2025
Divergent Delivery and Expression Kinetics of Lipid and Polymeric Nanoparticles across mRNA ModalitiesIrafasha C Casmil, Josh J Friesen, Nuthan V Bathula, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2026
Enhanced Efficacy of a Next-Generation EEEV Self-Replicating RNA Platform for Combination Cancer ImmunotherapiesShigeki J Miyake-Stoner, Christian J Maine, Annie C Chou, et al.
Science Advances|November 5, 2020
CD8<sup>+</sup> T cells mediate protection against Zika virus induced by an NS3-based vaccineAnnie Elong Ngono, Thasneem Syed, Anh-Viet Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2020
Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial ApproachChristian J Maine, Guilhem Richard, Darina S Spasova, et al.
Nature Communications|January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteersChristian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Communications Medicine|September 24, 2025
Durability of next-generation self-replicating RNA vaccine RBI-4000: a phase 1, randomized open label clinical trialChristian J Maine, Gaelle Picarda, Shigeki J Miyake-Stoner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 12, 2025
Divergent Delivery and Expression Kinetics of Lipid and Polymeric Nanoparticles across mRNA ModalitiesIrafasha C Casmil, Josh J Friesen, Nuthan V Bathula, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 27, 2026
Enhanced Efficacy of a Next-Generation EEEV Self-Replicating RNA Platform for Combination Cancer ImmunotherapiesShigeki J Miyake-Stoner, Christian J Maine, Annie C Chou, et al.
Science Advances|November 5, 2020
CD8<sup>+</sup> T cells mediate protection against Zika virus induced by an NS3-based vaccineAnnie Elong Ngono, Thasneem Syed, Anh-Viet Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2020
Self-Replicating RNAs Drive Protective Anti-tumor T Cell Responses to Neoantigen Vaccine Targets in a Combinatorial ApproachChristian J Maine, Guilhem Richard, Darina S Spasova, et al.
Nature Communications|January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteersChristian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
Pageof 2